PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 5906443

Adrenocortical function during intermittent corticosteroid therapy.

D A Adams·E M Gold·H C Gonick·M H Maxwell
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

DexamethasoneGlomerulonephritisNephrotic SyndromePituitary-Adrenal Function TestsPrednisoneJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D A Adams, E M Gold, H C Gonick, M H Maxwell. 1966. Adrenocortical function during intermittent corticosteroid therapy.. https://doi.org/10.7326/0003-4819-64-3-542

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Regulation of alpha 1-antichymotrypsin synthesis in cells of epithelial origin.

Oncostatin M, interleukin-1 and the glucocorticoid analog, dexamethasone, have been identified as potent stimulators of alpha 1-antichymotrypsin production in various cells of epithelial origin. Although being able to act individually, these factors exerted a dramatic increase in alpha 1-antichymotrypsin synthesis when administrated in combination. Their stimulatory effect was independent of the levels of constitutive synthesis of this inhibitor, which was already high in lung- and breast- and low in skin-derived epithelial cells. Since alpha 1-antichymotrypsin controls chymotrypsin-like proteinases which are released during inflammation, these data support the concept that local synthesis of this inhibitor may be important in reducing tissue damage associated with this process.

Dexamethasone↗